5-hydroxyindolacetic acid (5-HIAA), a main metabolite of serotonin, is responsible for complete Freund's adjuvant-induced thermal hyperalgesia in mice

Molecular Pain

Volumn 7, Issue , 2011, Pages

  Chen, Yong ^a   Palm, Florian ^a   Lesch, Klaus Peter ^a   Gerlach, Manfred ^a   Moessner, Rainald ^b   Sommer, Claudia ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; FENCLONINE; FREUND ADJUVANT; METHYSERGIDE; SEROTONIN; SEROTONIN ANTAGONIST; SEROTONIN TRANSPORTER; SEROTONIN AGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; HEAT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HINDLIMB; HYPERALGESIA; INFLAMMATION; MOUSE; NONHUMAN; PAIN; PAIN THRESHOLD; PAW EDEMA; PRIORITY JOURNAL; SCIATIC NERVE; SPINAL CORD; TISSUE LEVEL; WILD TYPE; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; GENETICS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; BEHAVIOR, ANIMAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FENCLONINE; FREUND'S ADJUVANT; HYDROXYINDOLEACETIC ACID; HYPERALGESIA; METHYSERGIDE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN RECEPTOR AGONISTS;

EID: 79953080065     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-7-21     Document Type: Article

References (40)

1. Eide PK, Hole K. The role of 5-hydroxytryptamine (5-HT) receptor subtypes and plasticity in the 5-HT systems in the regulation of nociceptive sensitivity. Cephalalgia 1993, 13:75-85. 10.1046/j.1468-2982.1993.1302075.x, 7684323.
2. Fields HL, Heinricher MM, Mason P. Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci 1991, 14:219-245. 10.1146/annurev.ne.14.030191.001251, 1674413.
3. Li P, Zhuo M. Silent glutamatergic synapses and nociception in mammalian spinal cord. Nature 1998, 393:695-698. 10.1038/31496, 9641681.
4. Millan MJ. Descending control of pain. Prog Neurobiol 2002, 66:355-474. 10.1016/S0301-0082(02)00009-6, 12034378.
5. Oliva P, Aurilio C, Massimo F, Grella A, Maione S, Grella E, Scafuro M, Rossi F, Berrino L. The antinociceptive effect of tramadol in the formalin test is mediated by the serotonergic component. Eur J Pharmacol 2002, 445:179-185. 10.1016/S0014-2999(02)01647-3, 12079682.
6. Sommer C. Serotonin in pain and analgesia. Mol Neurobiol 2004, 30:117-125. 10.1385/MN:30:2:117, 15475622.
7. Suzuki R, Rygh LJ, Dickenson AH. Bad news from the brain: descending 5-HT pathways that control spinal pain processing. Trends Pharmacol Sci 2004, 25:613-617. 10.1016/j.tips.2004.10.002, 15530638.
8. Zhuo M, Gebhart GF. Spinal serotonin receptors mediate descending facilitation of a nociceptive reflex from the nuclei reticularis gigantocellularis and gigantocellularis pars alpha in the rat. Brain Res 1991, 550:35-48. 10.1016/0006-8993(91)90402-H, 1888999.
9. Lesch KP. Serotoninergic neurons and 5-HT receptors in the CNS. Handbook of Experimental Pharmacology 1997, 129:671-705.
10. Blakely RD, De Felice LJ, Hartzell HC. Molecular physiology of norepinephrine and serotonin transporters. J Exp Biol 1994, 196:263-281.
11. Hyttel J. Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmacol 1994, 9:s19-26.
12. Fabre V, Boutrel B, Hanoun N, Lanfumey L, Fattaccini CM, Demeneix B, Adrien J, Hamon M, Martres MP. Homeostatic regulation of serotonergic function by the serotonin transporter as revealed by nonviral gene transfer. J Neurosci 2000, 20:5065-5075.
13. Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, Mossner R, Westphal H, Lesch KP. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol 1998, 53:649-655.
14. Vogel C, Mossner R, Gerlach M, Heinemann T, Murphy DL, Riederer P, Lesch KP, Sommer C. Absence of thermal hyperalgesia in serotonin transporter-deficient mice. J Neurosci 2003, 23:708-715.
15. Matsumoto M, Togashi H, Yoshioka M, Hirokami M, Tochihara M, Ikeda T, Smith CB, Saito H. Inhibitory effects of clonidine on serotonergic neuronal activity as measured by cerebrospinal fluid serotonin and its metabolite in anesthetized rats. Life Sci 1993, 53:615-620. 10.1016/0024-3205(93)90270-D, 8102468.
16. Koe BK, Weissman A. p-Chlorophenylalanine: a specific depletor of brain serotonin. J Pharmacol Exp Ther 1966, 154:499-516.
17. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1998, 32:77-88.
18. Palm F, Mössner R, Chen Y, He L, Gerlach M, Bischofs S, Riederer P, Lesch KP, Sommer C. Reduced thermal hyperalgesia and enhanced peripheral nerve injury after hind paw inflammation in mice lacking the serotonin-transporter. Eur J Pain 2008, 12:790-797. 10.1016/j.ejpain.2007.11.009, 18187350.
19. Harder JA, Kelly ME, Cheng CH, Costall B. Combined pCPA and muscarinic antagonist treatment produces a deficit in rat water maze acquisition. Pharmacol Biochem Behav 1996, 55:61-65. 10.1016/0091-3057(96)00049-4, 8870039.
20. Hadley SD, Walker PD, Goshgarian HG. Effects of the serotonin synthesis inhibitor p-CPA on the expression of the crossed phrenic phenomenon 4 h following C2 spinal cord hemisection. Exp Neurol 1999, 160:479-488. 10.1006/exnr.1999.7240, 10619565.
21. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 1994, 46:157-203.
22. Jequier E, Lovenberg W, Sjoerdsma A. Tryptophan hydroxylase inhibition: the mechanism by which p-chlorophenylalanine depletes rat brain serotonin. Mol Pharmacol 1967, 3:274-278.
23. Steinman JL, Carlton SM, Haber B, Willis WD. Differential effects of p-chlorophenylalanine on indoleamines in brainstem nuclei and spinal cord of rats. I. Biochemical and behavioral analysis. Brain Res 1987, 426:297-309. 10.1016/0006-8993(87)90883-3, 2446710.
24. Tran-Nguyen LT, Baker DA, Grote KA, Solano J, Neisewander JL. Serotonin depletion attenuates cocaine-seeking behavior in rats. Psychopharmacology (Berl) 1999, 146:60-66. 10.1007/s002130051088, 10485965.
25. Tohyama Y, Takahashi S, Merid MF, Watanabe A, Diksic M. The inhibition of tryptophan hydroxylase, not protein synthesis, reduces the brain trapping of alpha-methyl -L-tryptophan: an autoradiographic study. Neurochem Int 2002, 40:603-610. 10.1016/S0197-0186(01)00132-2, 11900855.
26. Eschalier A, Kayser V, Guilbaud G. Influence of a specific 5-HT3 antagonist on carrageen-induced hyperalgesia in rats. Pain 1989, 36:249-255. 10.1016/0304-3959(89)90030-4, 2919105.
27. Doak GJ, Sawynok J. Formalin-induced nociceptive behavior and edema: involvement of multiple peripheral 5-hydroxytryptamine receptor subtypes. Neuroscience 1997, 80:939-949. 10.1016/S0306-4522(97)00066-3, 9276504.
28. De Resende MA, Pimenta Dos Rei WG, Pereira LS, Ferreira W, Perez Garcia MH, Santoro MM, Nogueira de Francischi J. Hyperalgesia and edema responses induced by rat peripheral blood mononuclear cells incubated with carrageenin. Inflammation 2001, 25:277-285. 10.1023/A:1012812124461, 11820454.
29. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996, 87:2095-2147.
30. Liles WC, Van Voorhis WC. Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. J Infect Dis 1995, 172:1573-1580. 10.1093/infdis/172.6.1573, 7594719.
31. Janson W, Stein C. Peripheral opioid analgesia. Curr Pharm Biotechnol 2003, 4:270-274. 10.2174/1389201033489766, 14529429.
32. Watkins LR, Maier SF, Goehler LE. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 1995, 63:289-302. 10.1016/0304-3959(95)00186-7, 8719529.
33. Sawynok J, Reid A. Peripheral interactions between dextromethorphan, ketamine and amitriptyline on formalin-evoked behaviors and paw edema in rats. Pain 2003, 102:179-186. 10.1016/s0304-3959(02)00373-1, 12620609.
34. Lotsch J, Tegeder I, Angst MS, Geisslinger G. Antinociceptive effects of morphine -6-glucuronide in homozygous MDR1a P-glycoprotein knockout and in wildtype mice in the hotplate test. Life Sci 2000, 66:2393-2403. 10.1016/S0024-3205(00)00569-5, 10864101.
35. Shimoyama M, Shimoyama N, Gorman AL, Elliott KJ, Inturrisi CE. Oral ketamine is antinociceptive in the rat formalin test: role of the metabolite, norketamine. Pain 1999, 81:85-93. 10.1016/S0304-3959(98)00269-3, 10353496.
36. Goettl VM, Larson AA. Nitric oxide mediates long-term hyperalgesic and antinociceptive effects of the N-terminus of substance P in the formalin assay in mice. Pain 1996, 67:435-441. 10.1016/0304-3959(96)03155-7, 8951939.
37. Pang CS, Tsang SF, Yang JC. Effects of melatonin, morphine and diazepam on formalin-induced nociception in mice. Life Sci 2001, 68:943-951. 10.1016/S0024-3205(00)00996-6, 11213364.
38. Raghavendra V, Agrewala JN, Kulkarni SK. Melatonin reversal of lipopolysacharides-induced thermal and behavioral hyperalgesia in mice. Eur J Pharmacol 2000, 395:15-21. 10.1016/S0014-2999(00)00196-5, 10781668.
39. Yu CX, Zhu CB, Xu SF, Cao XD, Wu GC. Selective MT(2) melatonin receptor antagonist blocks melatonin-induced antinociception in rats. Neurosci Lett 2000, 282:161-164. 10.1016/S0304-3940(00)00883-1, 10717416.
40. Sawicki J, Kuzma M, Baranczyk-Kuzma A. The effect of serotonin, its precursors and metabolites on brain glutathione-S-transferase. Neurochem Res 2001, 26:469-472. 10.1023/A:1010948509478, 11513471.